Business

Zydus Lifesciences Limited Press Release Aug 21 2026

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 21, 2026, titled "Zydus announces final approval from the USFDA for Ascorbic Acid Injection with 180-Days CGT exclusivity".

Zydus Lifesciences LimitedAugust 21, 20263
Zydus Lifesciences Limited Press Release Aug 21 2026

About this update from Zydus Lifesciences Limited

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 21, 2026, titled "Zydus announces final approval from the USFDA for Ascorbic Acid Injection with 180-Days CGT exclusivity". View Attachment

View stock analysis, news, and events for Zydus Lifesciences Limited

More from Zydus Lifesciences Limited

Zydus Lifesciences Limited Press Release Aug 25 2026

August 25, 2026

Zydus Hospitals Sets New Benchmarks in High-Risk Pregnancy and Complex Gynaecological Care

August 18, 2026

All Zydus Lifesciences Limited news →